Reportlinker Adds Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis

NEW YORK, May 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis

http://www.reportlinker.com/p0201768/Global-Top-10-Biotechnology-Companies--Industry-Financial-and-SWOT-Analysis.html

Introduction

This report analyzes the global biotechnology market in terms of market size (reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding), key drivers and resistors, trends and competitive positioning. It includes profiles of the top ten companies in the industry along with 5-year financial analysis and in-depth SWOT analysis.

Scope

*Performance of the global biotechnology market on the basis of sales, volume and respective growth patterns over the past five years

*Obtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the last 12 months

*Analysis of the Strengths, Weaknesses, Opportunities and Threats of the top 10 biotechnology companies along with business overview and financials

*Benchmark the performance of the top 10 players for the past five years; includes revenue comparison, profitability analysis, industry-specific ratios

Highlights

The global biotechnology market grew by 10.6% in 2007 to reach a value of $171,803 million.

In 2012, the global biotechnology market is forecast to have a value of $275,757 million, an increase of 60.5% over 2007.

In value terms, the medical/healthcare segment generated 69.4% of the global biotechnology market value.

Reasons to Purchase

*Save time, money and resources on analyzing the top 10 biotechnology companies using this report

*Analyze the global biotechnology market with key industry metrics including market value, market volume, and growth forecasts

*Assess the intensity of competition based on the 5-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power

Table of Contents 2

FIGURES 3

Tables 4

Executive Summary 5

Industry analysis 5

Industry definition 5

Research highlights 5

Top 10 companies landscape 6

Top 10 companies landscape 6

Market Value 7

Market Forecast 8

Market Segmentation-Product 9

Market Segmentation-Geographic 10

Five Forces Analysis 11

Summary 11

Buyer power 12

Supplier power 13

New entrants 14

Substitutes 15

Rivalry 16

Top 10 Companies Landscape 17

Top 10 Companies Landscape 17

Amgen 18

Genentech 18

Gilead Sciences 19

UCB 19

Genzyme 19

Biogen Idec 19

CSL 19

Celgene 19

Cephalon 20

Actelion 20

Revenue analysis 21

Financial performance analysis 23

Operating profit analysis 24

Net profit analysis 25

Ratio analysis 26

Company Reports 28

Amgen 28

Company overview 28

Business description 28

SWOT analysis 29

Strengths 29

Weaknesses 29

Opportunities 30

Threats 31

Recent developments 32

Genentech 33

Company overview 33

Business description 33

SWOT analysis 34

Strengths 34

Weaknesses 35

Opportunities 36

Threats 37

Recent developments 37

Gilead Sciences 38

Company overview 38

Business description 38

SWOT analysis 39

Strengths 39

Weaknesses 39

Opportunities 39

Threats 40

Recent developments 41

UCB 42

Company overview 42

Business description 42

SWOT analysis 43

Strengths 43

Weaknesses 44

Opportunities 44

Threats 45

Recent developments 45

Genzyme 47

Company overview 47

Business description 47

SWOT analysis 48

Strengths 48

Weaknesses 49

Opportunities 49

Threats 50

Recent developments 50

Biogen Idec 52

Company overview 52

Business description 52

SWOT analysis 53

Strengths 53

Weaknesses 53

Opportunities 54

Threats 54

Recent developments 55

CSL 56

Company overview 56

Business description 56

SWOT analysis 57

Strengths 57

Weaknesses 58

Opportunities 58

Threats 59

Recent developments 60

Celgene 61

Company overview 61

Business description 61

SWOT analysis 61

Strengths 61

Weaknesses 62

Opportunities 62

Threats 63

Recent developments 64

Cephalon 65

Company overview 65

Business description 65

SWOT analysis 66

Strengths 66

Weaknesses 66

Opportunities 66

Threats 67

Recent developments 68

Actelion 69

Company overview 69

Business description 69

SWOT analysis 70

Strengths 70

Weaknesses 70

Opportunities 71

Threats 72

Recent developments 72

Financial Analysis 73

Amgen 73

Genentech 76

Gilead Sciences 79

UCB 82

Genzyme 85

Biogen Idec 88

CSL 91

Celgene 94

Cephalon 97

Actelion 100

Appendix 103

List of Tables

Table 1: Global biotechnology market, $ million, 2003-07 7

Table 2: Global biotechnology market forecast, $ million, 2007-12 8

Table 3: Global biotechnology market segmentation-product , % share, 2007 9

Table 4: Global biotechnology market segmentation-geography, % share, 2007 10

Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008 17

Table 6: Revenue growth of global top 10 biotechnology companies, 2006-08 21

Table 7: Key financials of global top 10 biotechnology companies, FY2008 23

Table 8: Key industry specific ratios, FY2008 26

Table 9: Amgen-Financial and operational highlights, 2004-08 ($ million) 73

Table 10: Amgen-Key industry specific ratios, 2004-2008 75

Table 11: Genentech-Financial and operational highlights, 2004-08 ($ million) 76

Table 12: Genentech-Key industry specific ratios, 2004-08 78

Table 13: Gilead Sciences-Financial and operational highlights, 2004-08 ($ million) 79

Table 14: Gilead Sciences-Key industry specific ratios, 2004-08 81

Table 15: Part(A) UCB-Financial and operational highlights, 2004-08 ($ million) 82

Table 16: Part(B) UCB-Financial and operational highlights, 2004-08 ($ million) 83

Table 17: UCB-Key industry specific ratios, 2004-08 84

Table 18: Genzyme-Financial and operational highlights, 2004-08 ($ million) 85

Table 19: Genzyme-Key industry specific ratios, 2004-08 87

Table 20: Biogen Idec-Financial and operational highlights, 2004-08 ($ million) 88

Table 21: Biogen Idec-Key industry specific ratios, 2004-08 90

Table 22: CSL-Financial and operational highlights, 2004-08 ($ million) 91

Table 23: CSL-Key industry specific ratios, 2004-08 93

Table 24: Celgene- Financial and operational highlights, 2004-08 ($ million) 94

Table 25: Celgene-Key industry specific ratios, 2004-08 96

Table 26: Cephalon-Financial and operational highlights, 2004-2008 ($ million) 97

Table 27: Cephalon-Key industry specific ratios, 2004-08 99

Table 28: Actelion-Financial and operational highlights, 2004-08 ($ million) 100

Table 29: Actelion-Key industry specific ratios, 2004-08 102

List of Figures

Figure 1: Global biotechnology market, $ million, 2003-07 7

Figure 2: Global biotechnology market forecast, $ million, 2007-12 8

Figure 3: Global biotechnology market segmentation-product, % share, 2007 9

Figure 4: Global biotechnology market segmentation-geography, % share, 2007 10

Figure 5: Forces driving competition in the global biotechnology market 11

Figure 6: Drivers of buyer power in the global biotechnology market 12

Figure 7: Drivers of supplier power in the global biotechnology market 13

Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market 14

Figure 9: Factors influencing the threat of substitutes in the global biotechnology market 15

Figure 10: Drivers of degree of rivalry in the global biotechnology market 16

Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008 18

Figure 12: Revenue growth of global top 10 biotechnology companies, 2006-08 22

Figure 13: Operating performance analysis, FY2008 24

Figure 14: Net profit analysis, FY2008 25

To order this report:

Biotechnology Industry: Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker